Kolinpharma portfolio

KOLINPHARMA® S.p.A. presents the new product IVUXUR® TABLETS, which is added to the other 9 patented or patent pending products, already present in the portfolio.

Company presentation - business model, product portfolio, financial data

KIP®KIT is a kit that contains:- KIP®Flu, a supplement formulated to support immun function, 
- hand sanitizing gel and 
- a washable and reusable mask. 

Kolinpharma® expands on the European market and obtains the patent for 3 products with validation in 12 new countries.

Video of Kolinpharma's story

Dolatrox® is a composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate. This composition was thus recognized as innovative and unique. Dolatrox is the 4th patent that Kolinpharma obtains in the USA.

KOLINPHARMA® ranks 359th in the fourth edition of the FT1000 2020 Europe's Fastest Growing Companies of the Financial Times.

This is a further confirmation of the commitment of KOLINPHARMA® aimed at protecting and enhancing the know-how and investments made in R&D.